Menaka Bhor
GRWE Director
Greater Houston · 1 connectionSobi - Swedish Orphan Biovitrum AB (publ)
Not on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
With over 18 years of experience in health economics and outcomes research, I am now Director of HEOR & RWE (North America) at Sobi focusing on rare disease. My journey in HEOR has equipped me with a robust skill set in developing and executing integrated Value Evidence Plans in multiple therapeutic areas with a positive impact. Expert in: • Value Evidence & Outcomes Research • Health Economic Modeling • Real-World Evidence (RWE) generation • Regulatory strategy and FDA interactions • Cross-functional collaboration • Patient-Reported Outcomes (PRO) • Market Access and Pricing strategies Key Accomplishments: • Spearheaded the development of economic models for Bexsero, influencing critical NITAG decisions and pricing strategies. • Led a multicenter observational study in oncology, ensuring regulatory compliance and alignment with FDA guidance. • Developed comprehensive economic models for Barrett’s esophagus, enhancing clinical validation and stakeholder engagement. • Supported market access strategies for advanced treatments in sickle cell disease, collaborating with teams to deliver compelling evidence packages. Let's connect to discuss how we can collaborate on innovative healthc
Experience
Education
Doctor of Philosophy (PhD) Pharmacy Administration and Pharmacy Policy and Regulatory Affairs
2000 to 2006